Effect of the amyloidogenic L75P apolipoprotein A-I variant on HDL subpopulations

Clinica Chimica Acta

Volumn 412, Issue 13-14, 2011, Pages 1262-1265

  Gomaraschi, Monica ^a   Obici, Laura ^b   Simonelli, Sara ^a   Gregorini, Gina ^c   Negrinelli, Alessandro ^c   Merlini, Giampaolo ^b   Franceschini, Guido ^a   Calabresi, Laura ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Division of Nefrology   (Italy)

Author keywords

Apolipoprotein A I; HDL subpopulations; High density lipoproteins; LCAT

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AMYLOIDOSIS; ARTICLE; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HETEROZYGOTE; HUMAN; HYPOALPHALIPOPROTEINEMIA; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROTEIN VARIANT;

AMYLOIDOSIS, FAMILIAL; APOLIPOPROTEIN A-I; CHOLESTEROL; DISEASE PROGRESSION; ESTERIFICATION; FEMALE; HETEROZYGOTE; HUMANS; LIPOPROTEINS, HDL; MALE; MIDDLE AGED; MUTATION;

EID: 79955476170     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.03.027     Document Type: Article

References (23)

1. Sipe J.D., Benson M.D., Buxbaum J.N., et al. Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid 2010, 17:101-104.
2. Obici L., Franceschini G., Calabresi L., et al. Structure, function and amyloidogenic propensity of apolipoprotein A-I. Amyloid 2006, 13:191-205.
3. Bohne S., Sletten K., Menard R., et al. Cleavage of AL amyloid proteins and AL amyloid deposits by cathepsins B, K, and L. J Pathol 2004, 203:528-537.
4. Eriksson M., Schonland S., Yumlu S., et al. Hereditary apolipoprotein AI-associated amyloidosis in surgical pathology specimens: identification of three novel mutations in the APOA1 gene. J Mol Diagn 2009, 11:257-262.
5. Obici L., Palladini G., Giorgetti S., et al. Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated italian families. A new amyloidogenic apolipoprotein A-I mutation. Gastroenterology 2004, 126:1416-1422.
6. Murakami T., Michelagnoli S., Longhi R., et al. Triglycerides are major determinants of cholesterol esterification/transfer and HDL remodeling in human plasma. Arterioscler Thromb Vasc Biol 1995, 15:1819-1828.
7. Calabresi L., Pisciotta L., Costantin A., et al. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol 2005, 25:1972-1978.
8. Franceschini G., Calabresi L., Colombo C., Favari E., Bernini F., Sirtori C.R. Effects of fenofibrate and simvastatin on HDL-related biomarkers in low-HDL patients. Atherosclerosis 2007, 195:385-391.
9. Favari E., Lee M., Calabresi L., et al. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding Cassette Transporter A1- but not Scavenger Receptor Class B Type I-mediated lipid efflux to high density lipoprotein. J Biol Chem 2004, 279:9930-9936.
10. Marchesi M., Parolini C., Valetti C., et al. The intracellular quality control system down-regulates the secretion of amyloidogenic apolipoprotein A-I variants: a possible impact on the natural history of the disease. Biochim Biophys Acta 2011, 1812:87-93.
11. Mangione P., Sunde M., Giorgetti S., et al. Amyloid fibrils derived from the apolipoprotein AI Leu174Ser variant contain elements of ordered helical structure. Protein Sci 2001, 10:187-199.
12. Murphy C.L., Wang S., Weaver K., Gertz M.A., Weiss D.T., Solomon A. Renal apolipoprotein A-I amyloidosis associated with a novel mutant Leu64Pro. Am J Kidney Dis 2004, 44:1103-1109.
13. Rader D.J., Gregg R.E., Meng M.S., et al. In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res 1992, 33:755-763.
14. Cheung M.C., Nichols A.V., Blanche P.J., Gong E.L., Franceschini G., Sirtori C.R. Characterization of A-I-containing lipoproteins in subjects with A-IMilano variant. Biochim Biophys Acta 1988, 960:73-82.
15. Miccoli R., Bertolotto A., Navalesi R., et al. Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease. Circulation 1996, 94:1622-1628.
16. Bruckert E., von Eckardstein A., Funke H., et al. The replacement of arginine by cysteine at residue 151 in apolipoprotein A-I produces a phenotype similar to that of apolipoprotein A-IMilano. Atherosclerosis 1997, 128:121-128.
17. Tilly-Kiesi M., Zhang Q., Ehnholm S., et al. ApoA-IHelsinki (Lys107->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency. Arterioscler Thromb Vasc Biol 1995, 15:1294-1306.
18. Leren T.P., Bakken K.S., Daum U., et al. Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL- subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I. J Lipid Res 1997, 38:121-131.
19. Franceschini G., Baio M., Calabresi L., Sirtori C.R., Cheung M.C., Apolipoprotein A-IMilano Partial lecithin:cholesterol acyltransferase deficiency due to low levels of a functional enzyme. Biochim Biophys Acta 1990, 1043:1-6.
20. Calabresi L., Franceschini G., Burkybile A., Jonas A. Activation of lecithin cholesterol acyltransferase by a disulfide-linked apolipoprotein A-I dimer. Biochem Biophys Res Commun 1997, 232:345-349.
21. Sorci-Thomas M.G., Bhat S., Thomas M.J. Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices. Clin Lipidol 2009, 4:113-124.
22. Weers P.M., Patel A.B., Wan L.C., et al. Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation. J Lipid Res 2011, 52:35-44.
23. Muiesan M.L., Salvetti M., Paini A., et al. Carotid artery structural alterations in patients with apolipoprotein A-I amyloidosis (Leu75Pro). J Hyperten 2009, 27(Suppl. 4):S323.